JP2022502440A5 - - Google Patents

Info

Publication number
JP2022502440A5
JP2022502440A5 JP2021517338A JP2021517338A JP2022502440A5 JP 2022502440 A5 JP2022502440 A5 JP 2022502440A5 JP 2021517338 A JP2021517338 A JP 2021517338A JP 2021517338 A JP2021517338 A JP 2021517338A JP 2022502440 A5 JP2022502440 A5 JP 2022502440A5
Authority
JP
Japan
Prior art keywords
methyl
pyrazole
epiminocycloocta
hexahydro
methanone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021517338A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022502440A (ja
JP7413368B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/058241 external-priority patent/WO2020065614A1/en
Publication of JP2022502440A publication Critical patent/JP2022502440A/ja
Publication of JP2022502440A5 publication Critical patent/JP2022502440A5/ja
Priority to JP2023220520A priority Critical patent/JP2024038151A/ja
Application granted granted Critical
Publication of JP7413368B2 publication Critical patent/JP7413368B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021517338A 2018-09-28 2019-09-27 モノアシルグリセロールリパーゼ調節因子 Active JP7413368B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023220520A JP2024038151A (ja) 2018-09-28 2023-12-27 モノアシルグリセロールリパーゼ調節因子

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862738684P 2018-09-28 2018-09-28
US62/738,684 2018-09-28
PCT/IB2019/058241 WO2020065614A1 (en) 2018-09-28 2019-09-27 Monoacylglycerol lipase modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023220520A Division JP2024038151A (ja) 2018-09-28 2023-12-27 モノアシルグリセロールリパーゼ調節因子

Publications (3)

Publication Number Publication Date
JP2022502440A JP2022502440A (ja) 2022-01-11
JP2022502440A5 true JP2022502440A5 (cg-RX-API-DMAC7.html) 2023-03-23
JP7413368B2 JP7413368B2 (ja) 2024-01-15

Family

ID=68109429

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021517338A Active JP7413368B2 (ja) 2018-09-28 2019-09-27 モノアシルグリセロールリパーゼ調節因子
JP2023220520A Pending JP2024038151A (ja) 2018-09-28 2023-12-27 モノアシルグリセロールリパーゼ調節因子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023220520A Pending JP2024038151A (ja) 2018-09-28 2023-12-27 モノアシルグリセロールリパーゼ調節因子

Country Status (13)

Country Link
US (4) US20200102311A1 (cg-RX-API-DMAC7.html)
EP (1) EP3856179B1 (cg-RX-API-DMAC7.html)
JP (2) JP7413368B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210069079A (cg-RX-API-DMAC7.html)
CN (1) CN113164458B (cg-RX-API-DMAC7.html)
AU (1) AU2019349962A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021005936A2 (cg-RX-API-DMAC7.html)
CA (1) CA3111309A1 (cg-RX-API-DMAC7.html)
ES (1) ES3074921T3 (cg-RX-API-DMAC7.html)
MA (1) MA53722A (cg-RX-API-DMAC7.html)
MX (1) MX2021003661A (cg-RX-API-DMAC7.html)
TW (1) TW202035409A (cg-RX-API-DMAC7.html)
WO (1) WO2020065614A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7413368B2 (ja) 2018-09-28 2024-01-15 ヤンセン ファーマシューティカ エヌ.ベー. モノアシルグリセロールリパーゼ調節因子
MA53721A (fr) 2018-09-28 2021-09-15 Janssen Pharmaceutica Nv Modulateurs de la monoacylglycérol lipase
CA3156100A1 (en) 2019-09-30 2021-04-08 Janssen Pharmaceutica Nv Radiolabelled mgl pet ligands
CA3176946A1 (en) 2020-03-26 2021-09-30 Janssen Pharmaceutica Nv Monoacylglycerol lipase modulators
IL313987A (en) 2021-12-29 2024-08-01 Psy Therapeutics Inc Inhibiting monoacylglycerol lipase (magl)
JP2025501056A (ja) 2021-12-30 2025-01-17 シャンハイ ハンソー バイオメディカル カンパニー リミテッド 三環系誘導体阻害剤、その製造方法と応用

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4812462A (en) 1986-04-01 1989-03-14 Warner-Lambert Company 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
US4816463A (en) 1986-04-01 1989-03-28 Warner-Lambert Company Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity
WO1992005784A1 (en) 1990-10-02 1992-04-16 Warner-Lambert Company 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine derivatives and analogues as angiotensin ii receptor antagonists
MXPA05000945A (es) 2002-07-25 2005-05-16 Pharmacia Italia Spa Biciclo-pirazoles activos como inhibidores de la cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
US20060100233A1 (en) 2002-07-25 2006-05-11 Manuela Villa Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
FR2857363B1 (fr) 2003-07-10 2007-09-07 Aventis Pharma Sa 4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees compositions les contenant et utilisation
AR045037A1 (es) 2003-07-10 2005-10-12 Aventis Pharma Sa Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion.
DE602005022320D1 (de) 2004-08-23 2010-08-26 Merck Sharp & Dohme Kondensierte triazolderivate als dipeptidylpeptidase-iv-hemmer zur behandlung bzw. prävention von diabetes
EP1844003A4 (en) 2005-01-27 2010-09-22 Astrazeneca Ab NEW BIAROMATIC COMPOUNDS AS INHIBITORS OF THE P2X7 RECEPTOR
US7402596B2 (en) 2005-03-24 2008-07-22 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
WO2006110516A1 (en) 2005-04-11 2006-10-19 Abbott Laboratories Acylhydrazide p2x7 antagonists and uses thereof
US7943617B2 (en) 2006-11-27 2011-05-17 Bristol-Myers Squibb Company Heterobicyclic compounds useful as kinase inhibitors
FR2915197B1 (fr) 2007-04-18 2009-06-12 Sanofi Aventis Sa Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
US8349858B2 (en) 2007-06-21 2013-01-08 Merck Sharp & Dohme Polycyclic guanine derivatives and use thereof
EP2185560A4 (en) 2007-08-10 2011-10-05 Lundbeck & Co As H HETEROARYLAMIDE ANALOGS
FR2921342B1 (fr) 2007-09-20 2010-03-12 Airbus France Carenage aerodynamique arriere inferieur pour dispositif d'accrochage d'un moteur d'aeronef
EP2090576A1 (en) 2008-02-01 2009-08-19 Merz Pharma GmbH & Co.KGaA 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators
JP5369173B2 (ja) 2008-04-22 2013-12-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ キノリン若しくはイソキノリン置換p2x7アンタゴニスト
US8309578B2 (en) 2008-11-25 2012-11-13 Nerviano Medical Sciences S.R.L. Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
WO2010066629A2 (en) 2008-12-09 2010-06-17 F. Hoffmann-La Roche Ag Novel azaindoles
WO2010125102A1 (en) 2009-04-29 2010-11-04 Glaxo Group Limited 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
GB0907515D0 (en) 2009-04-30 2009-06-10 Glaxo Group Ltd Compounds
US8871760B2 (en) 2009-09-21 2014-10-28 Roche Palo Alto Llc [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
EP2491031B1 (en) 2009-10-23 2013-08-07 Janssen Pharmaceutica N.V. Fused heterocyclic compounds as orexin receptor modulators
WO2011103715A1 (en) 2010-02-25 2011-09-01 Merck Sharp & Dohme Corp. Task channel antagonists
CA2793313C (en) 2010-04-02 2018-01-23 Euroscreen Sa Nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders
US20110252717A1 (en) 2010-04-16 2011-10-20 Graf Fernandez Rodrigo Foldable structures for a construction
US20130196986A1 (en) 2010-09-21 2013-08-01 Marc Labroli Triazolopyrazinones as p2x7 receptor antagonists
KR20130140020A (ko) 2010-10-22 2013-12-23 얀센 파마슈티카 엔.브이. 모노아실글리세롤 리파아제 억제제로서의 아미노-피롤리딘-아제티딘 다이아미드
JP2013540159A (ja) * 2010-10-22 2013-10-31 ヤンセン ファーマシューティカ エヌ.ベー. モノアシルグリセロールリパーゼ阻害剤としてのピペリジン−4−イル−アゼチジンジアミド
WO2012145581A1 (en) 2011-04-20 2012-10-26 Janssen Pharmaceutica Nv Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
IN2014CN02806A (cg-RX-API-DMAC7.html) * 2011-10-14 2015-07-03 Bristol Myers Squibb Co
US9273947B2 (en) 2012-02-07 2016-03-01 Lg Innotek Co., Ltd. Sensing magnet apparatus for motor
US9056874B2 (en) 2012-05-04 2015-06-16 Novartis Ag Complement pathway modulators and uses thereof
CA2874621A1 (en) 2012-05-22 2013-11-28 Genentech, Inc. N-substituted benzamides and their use in the treatment of pain
US8859774B2 (en) 2012-05-25 2014-10-14 Corcept Therapeutics, Inc. Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
JO3459B1 (ar) 2012-09-09 2020-07-05 H Lundbeck As تركيبات صيدلانية لعلاج مرض الزهايمر
BR112015008480A2 (pt) 2012-10-15 2017-07-04 Epizyme Inc compostos de benzeno substituído
MY189505A (en) 2012-10-16 2022-02-16 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of roryt
CA2888816A1 (en) 2012-11-01 2014-05-08 Incyte Corporation Tricyclic fused thiophene derivatives as jak inhibitors
US9796729B2 (en) 2012-11-23 2017-10-24 Glaxosmithkline Llc Compounds as diacylglycerol acyltransferase inhibitors
CA2895808A1 (en) 2012-12-21 2014-06-26 Quanticel Pharmaceuticals, Inc. Histone demethylase inhibitors
US9233974B2 (en) 2012-12-21 2016-01-12 Gilead Sciences, Inc. Antiviral compounds
ME03000B (me) 2012-12-21 2018-10-20 Plexxikon Inc Jedinjenja i metode modulacije kinaze i povezane indikacije
CN105188371A (zh) 2013-02-08 2015-12-23 西建阿维拉米斯研究公司 Erk抑制剂及其用途
NO335177B1 (no) 2013-03-06 2014-10-13 Cambi Technology As Fremgangsmåte og anordning for termisk biologisk nedbryting og avvanning av biomasse
JO3516B1 (ar) 2013-03-06 2020-07-05 Janssen Pharmaceutica Nv مُعدِّلات بنزإيميدازول-2-يل بيريميدين لمستقبل الهستامين h4
CN105189461B (zh) 2013-03-14 2018-05-15 葛兰素史克知识产权第二有限公司 2,3-二取代的1-酰基-4-氨基-1,2,3,4-四氢喹啉衍生物和它们作为溴结构域抑制剂的用途
JP6603649B2 (ja) 2013-03-14 2019-11-06 キュラデブ ファーマ プライベート リミテッド キヌレニン経路の阻害剤
ES2689526T3 (es) 2013-03-14 2018-11-14 Janssen Pharmaceutica Nv Moduladores de P2X7
JP6294953B2 (ja) 2013-03-14 2018-03-14 ヤンセン ファーマシューティカ エヌ.ベー. P2x7調節物質
CA2902174A1 (en) 2013-03-14 2014-10-02 Newlink Genetics Corporation Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization
EA029052B1 (ru) 2013-03-14 2018-02-28 Бёрингер Ингельхайм Интернациональ Гмбх Замещенные (бензилцианометил)амиды 2-азабицикло[2.2.1]гептан-3-карбоновых кислот в качестве ингибиторов катепсина с
US9242969B2 (en) 2013-03-14 2016-01-26 Novartis Ag Biaryl amide compounds as kinase inhibitors
JO3509B1 (ar) 2013-03-14 2020-07-05 Janssen Pharmaceutica Nv معدلات p2x7
JO3383B1 (ar) 2013-03-14 2019-03-13 Lilly Co Eli مثبطات cdc7
TWI599567B (zh) 2013-03-14 2017-09-21 健生藥品公司 P2x7調節劑
ES2721018T3 (es) 2013-03-29 2019-07-26 Ogeda S A N-Acil-(3-sustituido)-(8-metil)-5,6-dihidro-[1,2,4]triazolo[4,3-a]pirazinas como antagonistas selectivos del receptor NK-3, composición farmacéutica, métodos para su uso en trastornos mediados por el receptor de NK-3
WO2015025026A1 (en) 2013-08-22 2015-02-26 F. Hoffmann-La Roche Ag Alkynyl alcohols and methods of use
JP6715239B2 (ja) 2014-09-11 2020-07-01 ヤンセン ファーマシューティカ エヌ.ベー. 置換2−アザ二環式化合物及びオレキシン受容体調節因子としてのその使用
AU2015315693B2 (en) 2014-09-12 2020-01-16 Janssen Pharmaceutica Nv P2X7 modulating n-acyl-triazolopyrazines
WO2016039977A1 (en) 2014-09-12 2016-03-17 Janssen Pharmaceutica Nv P2x7 modulators
US10106556B2 (en) * 2015-03-30 2018-10-23 Takeda Pharmaceutical Company Limited Heterocyclic compound
WO2017087858A1 (en) 2015-11-20 2017-05-26 Abide Therapeutics, Inc. Pyrazole compounds and methods of making and using same
JP2020506903A (ja) * 2017-01-23 2020-03-05 ファイザー・インク Magl阻害薬としての複素環式スピロ化合物
JP7413368B2 (ja) 2018-09-28 2024-01-15 ヤンセン ファーマシューティカ エヌ.ベー. モノアシルグリセロールリパーゼ調節因子
MA53721A (fr) 2018-09-28 2021-09-15 Janssen Pharmaceutica Nv Modulateurs de la monoacylglycérol lipase
CN112272670B (zh) 2019-04-16 2023-12-12 上海翰森生物医药科技有限公司 含二并环类衍生物抑制剂、其制备方法和应用
CA3156100A1 (en) 2019-09-30 2021-04-08 Janssen Pharmaceutica Nv Radiolabelled mgl pet ligands
CA3176946A1 (en) 2020-03-26 2021-09-30 Janssen Pharmaceutica Nv Monoacylglycerol lipase modulators

Similar Documents

Publication Publication Date Title
JP2021528467A5 (cg-RX-API-DMAC7.html)
JP2022502424A5 (cg-RX-API-DMAC7.html)
HRP20240935T1 (hr) Heterociklični i heteroaril spojevi za liječenje huntingtonove bolesti
Murlykina et al. Aminoazole-based diversity-oriented synthesis of heterocycles
JP2016504363A5 (cg-RX-API-DMAC7.html)
JP2021519291A5 (cg-RX-API-DMAC7.html)
JP2021528466A5 (cg-RX-API-DMAC7.html)
RU2015131148A (ru) СОЕДИНЕНИЯ, ГЕТЕРОБИЦИКЛО-ЗАМЕЩЕННЫЕ-[1, 2, 4]ТРИАЗОЛО[1, 5c]ХИНАЗОЛИН-5-АМИНА, ОБЛАДАЮЩИЕ СВОЙСТВАМИ А2А АНТАГОНИСТОВ
RU2018112230A (ru) Бициклические соединения в качестве ингибиторов atx
IL216247A (en) Tetrahydrobenzazepine-conjugated and terroyl-containing and used to prevent the reabsorption of norepinephrine, dopamine and serotonin
HRP20120105T1 (hr) Aminoheterociklički spojevi
ME02330B (me) Derivati 2,3-dihidro-1h-inden-1-il-2,7-diazaspir0[3.6]nonana i njihova upotreba kao antagonista ili inverznih agonista grelinskog receptora
Elwahy et al. Synthesis of trifluoromethyl-substituted fused bicyclic heterocycles and their corresponding benzo-fused analogues
JP2021512954A5 (cg-RX-API-DMAC7.html)
AU2024332123A1 (en) Compositions comprising werner syndrome helicase inhibitors and methods of using the same
JP2023549055A5 (cg-RX-API-DMAC7.html)
RU2012136907A (ru) Модуляторы гамма-секретазы
HRP20210403T1 (hr) Azabenzimidazoli i njihova uporaba kao modulatora ampa receptora
RU2015129538A (ru) Замещенные имидазопиридины в качестве ингибиторов hdm2
JP2015511245A5 (cg-RX-API-DMAC7.html)
RU2017105296A (ru) Новые соединения
JP2017518326A5 (cg-RX-API-DMAC7.html)
JP2012527483A5 (cg-RX-API-DMAC7.html)
JP2023520759A5 (cg-RX-API-DMAC7.html)
JP2009538896A5 (cg-RX-API-DMAC7.html)